1. Home
  2. PTGX
  3. PTGX News

Latest Protagonist Therapeutics Inc. (PTGX) News on May 28, 2024

Protagonist Therapeutics Announces Oral Presentation on Long-Term Follow-up of Rusfertide Phase 2 REVIVE Study Open Label Extension  at the European Hematology Association 2024 Congress

ACCESSWIRE

14 days ago

Protagonist Therapeutics Announces Oral Presentation on Long-Term Follow-up of Rusfertide Phase 2 REVIVE Study Open Label Extension at the European Hematology Association 2024 Congress

Associated Press Finance

4 months ago

Northwest Bancshares: Q4 Earnings Snapshot

Share on Social Networks: